Navigation Links
Obesity Drug Advertisements Misleading Teens

Advertisements for the weight loss drug Xenical has come under criticism from consumer watchdog, Choice saying that it is misleading young teenage girls//, preying on their fears about their bodies in a breach of advertising guidelines.

The ads have been screened during the high-rating Australian Idol program whose major audiences include 13- to 17-year-olds and have reportedly driven teens as young as 13 and of average weight to seek out the drugs from pharmacies.

Choice said that the ads breached the Therapeutic Goods Advertising Code Council's guidelines prohibiting drug advertising that are directed at people under 18. It has set the call for the withdrawal of the campaign.

Pharmacists have reported increased demands from customers of average weight during the two weeks since the drug has been directly advertised.

One pharmacist on an industry email list wrote, ‘Am I the only one who's noticed a sudden incidence, since the branded advertising started, of people requesting Xenical who have a [body mass index] of 25 or less?’.

"These [mainly female] patients look like they have a healthy weight, yet they're all telling me they want to lose another 5 to 10 kilograms."

Another pharmacist wrote: "I think we are going to be spending a lot of our time sorting out the few people for whom Xenical might be useful from the many who decide they want it, following promotion direct to consumer." However some others have considered that it would do no harm to provide the drug to those with a healthy weight, in spite of its known side effects such as diarrhea and incontinence.

Viola Korczak, the health policy officer at Choice said that the safety and efficacy of Xenical for children had not been established, adding, "Our concern is that parents may not even know that their children are taking these drugs."

Channel Ten markets Australian Idol as the place for advertisers to reach the youth and says the pro gram is able to capture more than 50 per cent of the 16- to 39-year-old audience. Of the 1.48 million people who tuned in on Monday, 320,000 were under 16.

A Ten spokeswoman reported that Xenical was not an Idol sponsor. It was reported to have had booked a small number of ads around the program but had no more planned. She said that the drug's manufacturer, Roche Products, had "cleared all the requisite hurdles" but that "Channel Ten is not in a position to second-guess the rulings of independent regulatory bodies".

David Henry, a professor of clinical pharmacology at the University of Newcastle said that placing the drug ad in the Australian Idol timeslot had everything to do with appearance and very little to do with health.

The complaint is to go before the council on October 19.

If Roche is found to be in breach of the code, it could be forced to withdraw the ad although it would not be fined. The company has denied marketing Xenical to adolescents, saying the advertising was aimed at an older audience.


NL
'"/>




Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Obesity raises IVF miscarriage risk
3. Obesity a risk for pancreatic cancer
4. Obesity shortens lifespan
5. Is Obesity a risk factor?
6. Obesity a global problem
7. Obesity increases health costs
8. Obesity in children a risk factor for diabetes
9. Decrease of Hunger Hormone after Obesity Surgery
10. Obesity risk for immobilized adults
11. Obesity risk can be reduced by eating breakfast regularly
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: